Galeazzi R, Lorenzini I, Orlandi F
Dig Dis Sci. 1980 Feb;25(2):108-12. doi: 10.1007/BF01308307.
Fasting and postprandial serum bile acid concentrations were determined by gas-liquid chromatography in 20 consecutive individuals (14 normal subjects, 6 cirrhotics) before and after administration of rifampicin in a single dose of 900 mg, using each individual as his own control. In the normal subjects the 2-hr postprandial level was 2.9 +/- 0.2 microM (mean +/- 1 SEM) prior to drug administration. Following rifampicin, it was 7.7 +/- 0.5 microM (P less than 0.0005). In the patients with liver cirrhosis the 2-hr postprandial level increased from 30.2 +/- 3.5 before, to 105.0 +/- 27.7 microM after rifampicin (P less than 0.025). Twelve hours after drug administration the levels of serum bile acids were not significantly different with respect to the control values. Total serum bilirubin also showed a transient and parallel increase. These findings are compatible with the hypothesis that rifampicin inhibits the hepatic transport of bile acids.
采用气液色谱法,以20名连续入选的个体(14名正常受试者,6名肝硬化患者)为自身对照,测定了单次服用900mg利福平前后的空腹及餐后血清胆汁酸浓度。正常受试者在给药前餐后2小时胆汁酸水平为2.9±0.2μM(均值±1标准误)。服用利福平后,该水平为7.7±0.5μM(P<0.0005)。肝硬化患者餐后2小时胆汁酸水平从给药前的30.2±3.5μM升至利福平给药后的105.0±27.7μM(P<0.025)。给药12小时后,血清胆汁酸水平与对照值无显著差异。血清总胆红素也出现了短暂且平行的升高。这些发现与利福平抑制胆汁酸肝脏转运的假说相符。